Demand for skilled and trained labour in pharma companies is on the rise considering India has the largest number of US FDA approved facilities outside the US.
The Indian Pharma industry is expected to expand at a CAGR of 22.4 per cent over 2015–20 to reach US$55 billion. As the industry grows, it becomes crucial to be watchful against business and workforce frauds and malpractices. Some of key measures to adopt include keeping an eye on instances of falsified credentials, verifying blue-collar employees and onboarding reliable business partners responsible for the influx of medicines and medical equipment. Background verification presents itself as a reliable solution.